New Market Research Report: Italy Pharmaceuticals & Healthcare Report Q4 2013
While the implementation of cost-containment policies targeting the pharmaceutical industry in Italy may work to prevent the healthcare expenditure budget from overshooting, in the long term such policies may lower incentives for structural reform of the health care sector. This is because in theory they do not guarantee the efficient provision and management of healthcare services. The Italian public sector operates through regional autonomous communities, resulting in a decentralised approach to drug procurement and healthcare provision.
View full press release